Tropisetron, another 5-HT3R antagonist, exhibits antidiabetic effects [400], which may be relevant for schizophrenia management given the high prevalence of metabolic syndrome associated with atypical antipsychotics. The gene discussed is HTR3A; the disease is schizophrenia.